Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-29

Clinical Trial Update: NEPHSTROM for Diabetic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial NEPHSTROM for diabetic kidney disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEPHSTROM

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Diabetic Kidney Disease | Phase 1, Phase 2 | Status: TERMINATED